Rock Creek Pharma (RCPI) Completes Anatabine Citrate Phase 1 Trial in U.K.
Tweet Send to a Friend
Rock Creek Pharma (NASDAQ: RCPI) announced the successful completion of its three part Phase I clinical trial conducted in the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE